HOFBF (Hofseth BioCare ASA) YoY EBITDA Growth: 50.00% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HOFBF Hofseth BioCare ASA HOFBF
61 GF Score
Price $0.17
GF Value $0.22
! 5 Warning Signs
View Full Analysis

What is Hofseth BioCare ASA YoY EBITDA Growth?

Hofseth BioCare ASA HOFBF 61 YoY EBITDA Growth is 50.00% as of Jun. 2026. GuruFocus rates HOFBF with a GF Score™ of 61/100 and a GF Value™ of $0.22. The stock has 5 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Hofseth BioCare ASA's YoY EBITDA Growth for the quarter that ended in Jun. 2026 was 50.00%.

Hofseth BioCare ASA's EBITDA per Share for the three months ended in Jun. 2026 was $-0.00.

Hofseth BioCare ASA YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Hofseth BioCare ASA's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hofseth BioCare ASA YoY EBITDA Growth Chart

Hofseth BioCare ASA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -17.39 3.70 42.31 0.00 -13.33

Hofseth BioCare ASA Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -100.00 40.00 -16.67 -25.00 50.00
HOFBF
61GF Score
Hofseth BioCare ASA HOFBF
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hofseth BioCare ASA YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Hofseth BioCare ASA's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(-0.017--0.015)/ | -0.015 |
=-13.33 %

Hofseth BioCare ASA's YoY EBITDA Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EBITDA Growth (Q: Jun. 2026 )
=(EBITDA per Share (Q: Jun. 2026 )-EBITDA per Share (Q: Jun. 2025 )) / | EBITDA per Share (Q: Jun. 2025 )) |
=(-0.001--0.002)/ | -0.002 |
=50.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 50.00% mean?
Hofseth BioCare ASA (HOFBF) has a YoY EBITDA Growth of 50.00% as of Jun. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Hofseth BioCare ASA and its competitors.
Is Hofseth BioCare ASA's YoY EBITDA Growth too high?
Hofseth BioCare ASA's current YoY EBITDA Growth is 50.00%. Overall, Hofseth BioCare ASA has a GF Score™ of 61/100, reflecting its overall financial health beyond just this single metric.
How does Hofseth BioCare ASA's YoY EBITDA Growth compare to KHC and GIS?
Hofseth BioCare ASA's YoY EBITDA Growth of 50.00% can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Consumer Packaged Goods company?
A good YoY EBITDA Growth depends on the Consumer Packaged Goods industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Hofseth BioCare ASA and its competitors. Hofseth BioCare ASA's current YoY EBITDA Growth is 50.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hofseth BioCare ASA stock overvalued right now?
Hofseth BioCare ASA (HOFBF) has a current YoY EBITDA Growth of 50.00%. The stock's GF Value™ is $0.22, compared to a current price of $0.17 — trading 24.3% below its estimated fair value. The current YoY EBITDA Growth is 50.00%. Hofseth BioCare ASA's overall GF Score™ is 61/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Hofseth BioCare ASA (HOFBF), the current YoY EBITDA Growth is 50.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hofseth BioCare ASA (HOFBF) Overvalued in 2026?

Based on GuruFocus' analysis, Hofseth BioCare ASA stock appears to be undervalued. The current stock price of $0.17 is trading 24.3% below its estimated GF Value™ of $0.22.

Key valuation signals for HOFBF:

  • YoY EBITDA Growth: 50.00%
  • GF Value™: $0.22 vs. price of $0.17 (24.3% below fair value)
  • GF Score™: 61/100 with 5 warning signs

No single metric tells the full story. See the HOFBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hofseth BioCare ASA Business Description

Address Keiser Wilhelmsgate 24, Aalesund, NOR, 6003
Hofseth BioCare ASA is a Norway-based company engaged in the business of developing, manufacturing, marketing, and selling marine ingredients such as oil, calcium, and protein products. Its brands, which also generate revenue, include salmon oil (OmeGo), water-soluble protein (ProGo), calcium/collagen (CalGo and NT-II), and non-soluble protein (PetGo), all of which are produced in the Midsund plant. The firm sells its products to various segments of the human nutrition market, such as sports nutrition, supplements, and health foods, as well as to the market within nutrition for the pet and feed industry. Geographically, the company generates maximum revenue from Europe, followed by North America and Asia.
61GF Score

Get the complete analysis for HOFBF

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.17
Price
$0.22
GF Value